Viking Therapeutics, Inc. (VKTX)
|8.01 0.02 (0.25%) 11-15 16:002019-11-15|
|Exchange:||NASDAQ Capital Market|
Viking Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops therapies for metabolic and endocrine disorders. It includes portfolio of five drug candidates in clinical trials or preclinical studies.
|Profit Margin (%)||0.00|
|Operating Margin (%)||0.00|
|Return on Assets (ttm)||-6.5|
|Return on Equity (ttm)||-8.1|
Wed, 06 Nov 2019 14:00:00 +0000Up 19.2%, Is Viking Therapeutics Stock Still a Buy?
Tue, 05 Nov 2019 20:24:09 +0000Noteworthy Tuesday Option Activity: AMZN, VKTX, PLT
Mon, 09 Sep 2019 14:00:00 +0000Better Buy: Intercept Pharmaceuticals vs. Viking Therapeutics
Tue, 13 Aug 2019 11:00:00 +00003 Top Small-Cap Stocks to Buy in August
Sun, 11 Aug 2019 13:15:00 +0000Is Viking Therapeutics a Buy?
Fri, 05 Apr 2019 00:10:49 +0000MACK Halts MM-310 Study, VKTX On Watch, NAII Hits New High
©Foxchart.com All Rights Reserved. Foxchart.com | United States NYSE NASDAQ AMEX stock markets, stock quotes and stock technical analysis charts. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither Foxchart.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX